Ticker Scorecard - GERN Basics Company: Geron Corporation IPO Date: July 31, 1996 Sector: Healthcare Industry: Biotech Market Cap: $1.76B Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 2.86% Avg Daily Range (30 D): $0.07 | 2.05% Avg Daily Range (90 D): $0.08 | 1.99% Institutional Daily Volume Avg Daily Volume: 2.56M Avg Daily Volume (30 D): 10.87M Avg Daily Volume (90 D): 8.26M Trade Size Avg Trade Size (Sh.): 334 Avg Trade Size (Sh.) (30 D): 458 Avg Trade Size (Sh.) (90 D): 360 Institutional Trades Total Inst.Trades: 2,341 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $3.23M Avg Inst. Trade (90 D): $2.35M Avg Inst. Trade Volume: .58M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.46M Avg Closing Trade (30 D): $3.46M Avg Closing Trade (90 D): $3.58M Avg Closing Volume: 791.68K     News Jul 24, 2024 @ 12:17 PM Tesla Posts Weak Earnings, Joins Visa, Deutsche Ba... Source: Avi Kapoor Jun 10, 2024 @ 3:58 PM Geron (GERN) Wins FDA Approval for Blood Cancer Dr... Source: Zacks Equity Research Jun 10, 2024 @ 1:00 PM Critical Insights From Geron Analyst Ratings: What... Source: Benzinga Insights Jun 8, 2024 @ 10:37 AM Is Geron Stock a Buy Following Its First New Drug ... Source: newsfeedback@fool.com (Cory Renauer) Jun 7, 2024 @ 3:30 PM Why Is Exact Sciences (EXAS) Down 17.5% Since Last... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.32 $-.04 $-.1 Diluted EPS $-.32 $-.04 $-.1 Revenue $ 29.48M $ 28.27M $ .88M Gross Profit $ $ $ Net Income / Loss $ -201.19M $ -26.45M $ -67.38M Operating Income / Loss $ -207.97M $ -28.22M $ -69.33M Cost of Revenue $ $ $ Net Cash Flow $ 30.95M $ -55.92M $ -72.79M PE Ratio